Asthma, atopy and exhaled nitric oxide in a cohort of 6-yr-old New Zealand children

To cite this article: Crane J, Lampshire P, Wickens K, Epton M, Siebers R, Ingham T, Pattemore P, Town GI and The Year Six New Zealand Asthma and Allergy Cohort Study Group (NZAACS6). Asthma, atopy and exhaled nitric oxide in a cohort of 6‐yr‐old New Zealand children. Pediatric Allergy Immunology 2012: 23: 59–64. Background: Exhaled nitric oxide has been promoted as a non‐invasive measure of airway inflammation, with clinical utility for the diagnosis and management of asthma. Aim: We studied associations between exhaled nitric oxide, asthma and atopy in a variety of clinically relevant phenotypes in a cohort of 6‐yr‐old children. Method: Asthma was defined using standard questionnaire criteria, atopy was measured using skin prick tests (SPT) and specific IgE to common allergens, and exhaled nitric oxide was measured using a chemiluminescence analyser according to American and European Thoracic Society criteria. Results: Exhaled nitric oxide was strongly related to atopy and in particular to sensitization to house dust mites. Children with non‐allergic asthma had no increase in exhaled nitric oxide compared with non‐asthmatic children. Compared with children who never wheezed both late onset and persistent, wheezing was associated with increased FENO, while early transient wheezing was not. Elevated levels of exhaled nitric oxide amongst children with allergic asthma were almost entirely explained by their levels of specific IgE to aeroallergens, predominantly D pteronyssinus. Conclusion: Airway inflammation as measured by exhaled nitric oxide in young New Zealand children is related to their level of specific IgE to aeroallergens. This has implications for the utility of nitric oxide as a diagnostic and management tool in childhood asthma and for the importance of specific IgE as a marker of asthma severity.